Literature DB >> 26467269

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.

Andrew P Ambrosy1, Adrian F Hernandez1,2, Paul W Armstrong3, Javed Butler4, Allison Dunning2, Justin A Ezekowitz3, G Michael Felker1,2, Stephen J Greene1, Padma Kaul3, John J McMurray5, Marco Metra6, Christopher M O'Connor1,2, Shelby D Reed2, Phillip J Schulte2, Randall C Starling7, W H Wilson Tang7, Adriaan A Voors8, Robert J Mentz1,2.   

Abstract

AIMS: A longitudinal and comprehensive analysis of health-related quality of life (HRQOL) was performed during hospitalization for heart failure (HF) or soon after discharge. METHODS AND
RESULTS: A post-hoc analysis was performed of the ASCEND-HF trial. The EuroQOL five dimensions questionnaire (EQ-5D) was administered to study participants at baseline, 24 h, discharge/day 10, and day 30. EQ-5D includes functional dimensions mapped to corresponding utility scores (i.e. 0 = death and 1 = perfect health), and a visual analogue scale (VAS) ranging from 0 (i.e. 'worst imaginable health state') to 100 (i.e. 'best imaginable health state'). The association between baseline and discharge EQ-5D measurements and subsequent clinical outcomes including death and rehospitalization were assessed using multivariable logistic regression and Cox proportional hazards regression. A total of 6943 patients (97%) had complete EQ-5D data at baseline. Mapped utility and VAS scores (mean ± SD) increased over time, respectively, from 0.56 ± 0.23 and 45 ± 22 at baseline to 0.67 ± 0.26 and 58 ± 22 at 24 h and to 0.79 ± 0.20 and 68 ± 22 at discharge, and remained stable at day 30. Lower mapped utility scores at baseline [odds ratio (OR) per 0.1 decrease in utility score 1.03, 95% confidence interval (CI) 1.00-1.06] and discharge (OR 1.10, 95% CI 1.05-1.15) and VAS scores at baseline (OR per 10 point decrease 1.05, 95% CI 1.01-1.09) were significantly associated with increased risk of 30-day all-cause death or HF rehospitalization.
CONCLUSIONS: Patients hospitalized for HF had severely impaired health status at baseline and, although this improved substantially during admission, health status remained abnormal at discharge.
© 2015 The Authors European Journal of Heart Failure © 2015 European Society of Cardiology.

Entities:  

Keywords:  Heart failure; Hospitalization; Morbidity; Mortality; Quality of life

Mesh:

Year:  2015        PMID: 26467269      PMCID: PMC4801656          DOI: 10.1002/ejhf.420

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  28 in total

1.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

2.  Strategies and opportunities for drug development in heart failure.

Authors:  Javed Butler; Gregg C Fonarow; Mihai Gheorghiade
Journal:  JAMA       Date:  2013-04-17       Impact factor: 56.272

3.  Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

Authors:  Andrew P Ambrosy; Peter S Pang; Sadiya Khan; Marvin A Konstam; Gregg C Fonarow; Brian Traver; Aldo P Maggioni; Thomas Cook; Karl Swedberg; John C Burnett; Liliana Grinfeld; James E Udelson; Faiez Zannad; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2013-01-04       Impact factor: 29.983

4.  Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.

Authors:  Marco Metra; John G Cleland; Beth Davison Weatherley; Howard C Dittrich; Michael M Givertz; Barry M Massie; Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-03-12       Impact factor: 15.534

5.  Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.

Authors:  Eldrin F Lewis; Marc A Pfeffer; Amy Feng; Hajime Uno; John J V McMurray; Robert Toto; Shravanthi R Gandra; Scott D Solomon; Moustafa Moustafa; Iain C Macdougall; Francesco Locatelli; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-06       Impact factor: 8.237

6.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.

Authors:  Marco Metra; Christopher M O'Connor; Beth A Davison; John G F Cleland; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Michael M Givertz; George A Mansoor; Daniel M Bloomfield; Gang Jia; Paul DeLucca; Barry Massie; Howard Dittrich; Gad Cotter
Journal:  Eur Heart J       Date:  2011-03-08       Impact factor: 29.983

7.  Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

Authors:  Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Craig J Reist; Paul W Armstrong; Kenneth Dickstein; Todd J Lorenz; W Brian Gibler; Vic Hasselblad; Michel Komajda; Barry Massie; John J V McMurray; Markku Nieminen; Jean L Rouleau; Karl Swedberg; Robert M Califf
Journal:  Am Heart J       Date:  2008-12-19       Impact factor: 4.749

8.  Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.

Authors:  Robert J Mentz; Adrian F Hernandez; Amanda Stebbins; Justin A Ezekowitz; G Michael Felker; Gretchen M Heizer; Dan Atar; John R Teerlink; Robert M Califf; Barry M Massie; Vic Hasselblad; Randall C Starling; Christopher M O'Connor; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-11-15       Impact factor: 15.534

9.  Heart failure–associated hospitalizations in the United States.

Authors:  Saul Blecker; Margaret Paul; Glen Taksler; Gbenga Ogedegbe; Stuart Katz
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

10.  Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION.

Authors:  Yanhong Li; Matthew P Neilson; David J Whellan; Kevin A Schulman; Wayne C Levy; Shelby D Reed
Journal:  J Card Fail       Date:  2013-05       Impact factor: 5.712

View more
  12 in total

1.  Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Authors:  Marat Fudim; Kishan S Parikh; Allison Dunning; Adam D DeVore; Robert J Mentz; Phillip J Schulte; Paul W Armstrong; Justin A Ezekowitz; W H Wilson Tang; John J V McMurray; Adriaan A Voors; Mark H Drazner; Christopher M O'Connor; Adrian F Hernandez; Chetan B Patel
Journal:  Am J Cardiol       Date:  2018-08-03       Impact factor: 2.778

2.  A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates.

Authors:  Gian Luca Di Tanna; Blake Angell; Michael Urbich; Peter Lindgren; Thomas A Gaziano; Gary Globe; Björn Stollenwerk
Journal:  Pharmacoeconomics       Date:  2022-08-12       Impact factor: 4.558

3.  Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial.

Authors:  Johan S Bundgaard; Kasper Iversen; Mia Pries-Heje; Nikolaj Ihlemann; Sabine U Gill; Trine Madsen; Hanne Elming; Jonas A Povlsen; Niels E Bruun; Dan E Høfsten; Kurt Fuursted; Jens J Christensen; Martin Schultz; Flemming Rosenvinge; Jannik Helweg-Larsen; Lars Køber; Christian Torp-Pedersen; Emil L Fosbøl; Niels Tønder; Claus Moser; Henning Bundgaard; Ulrik M Mogensen
Journal:  Qual Life Res       Date:  2022-03-29       Impact factor: 3.440

4.  Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.

Authors:  Justin T Parizo; Jeremy D Goldhaber-Fiebert; Joshua A Salomon; Kiran K Khush; John A Spertus; Paul A Heidenreich; Alexander T Sandhu
Journal:  JAMA Cardiol       Date:  2021-08-01       Impact factor: 30.154

5.  Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost-Utility Analysis.

Authors:  John K Peel; Rafael Neves Miranda; David Naimark; Graham Woodward; Mamas A Mamas; Mina Madan; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

6.  "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.

Authors:  Laurent Bailly; Philippe Mossé; Stéphane Diagana; Marion Fournier; Fabienne d'Arripe-Longueville; Odile Diagana; Jocelyn Gal; Jean Grebet; Mario Moncada; Jean-Jacques Domerego; Rémi Radel; Roxane Fabre; Alain Fuch; Christian Pradier
Journal:  BMC Cardiovasc Disord       Date:  2018-12-06       Impact factor: 2.298

7.  Using frailty and quality of life measures in clinical care of the elderly in Canada to predict death, nursing home transfer and hospitalisation - the frailty and ageing cohort study.

Authors:  Ted Rosenberg; Patrick Montgomery; Vikki Hay; Rory Lattimer
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

8.  Patient-Reported Outcomes From Patients With Heart Failure Participating in the Future Patient Telerehabilitation Program: Data From the Intervention Arm of a Randomized Controlled Trial.

Authors:  Cathrine Skov Schacksen; Anne-Kirstine Dyrvig; Nanna Celina Henneberg; Josefine Dam Gade; Helle Spindler; Jens Refsgaard; Malene Hollingdal; Lars Dittman; Kim Dremstrup; Birthe Dinesen
Journal:  JMIR Cardio       Date:  2021-07-02

9.  Association of gender and length of stay among Puerto Ricans hospitalized with decompensated heart failure.

Authors:  Mohammad A Alnajashi; Mohammed A Almasoud; Sami A Aldaham; Juan Manuel Acuña; Juan C Zevallos
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.

Authors:  Kelsey M Flint; John A Spertus; Fengming Tang; Philip Jones; Timothy J Fendler; Larry A Allen
Journal:  BMC Cardiovasc Disord       Date:  2017-03-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.